Pneumococcal Infections
📧 Sign up to get email alerts when something new happens for Pneumococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine [Phase 1, Phase 2]
Phase 1/2 trial evaluating a 26-valent pneumococcal conjugate vaccine has been completed.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab [Phase 3]
A Phase 3 clinical trial evaluating a prime-boost anti-pneumococcal vaccination strategy in patients with diffuse large B-cell lymphoma trea…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of a 13-valent pneumococcal polysaccharide conjugate vaccine; the study status is com…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response [NA]
A completed clinical trial investigated which B cell subsets mediate the antibody response to pneumococcal pathogens, shedding light on immu…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Extension Safety and Immunogenicity Study of GPNV-001 [Phase 1, Phase 2]
Completion of an extension safety and immunogenicity study for the GPNV-001 vaccine candidate in pneumococcal infections (Phase 1/2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders [Phase 1]
This Phase 1 trial reports immunogenicity and reactogenicity data for pneumococcal polysaccharide and conjugate vaccines in elderly particip…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3. [Phase 1]
Phase 1 study evaluating safety, tolerability, and immunogenicity of Gamma-PN3, an inactivated whole-cell pneumococcal vaccine. The trial ha…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Immunization To Prevent Acute COPD Exacerbations
Pfizer conducted an immunization trial aimed at preventing acute exacerbations of chronic obstructive pulmonary disease, which has been term…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children [Phase 3]
Phase 3 trial of the 13-valent pneumococcal conjugate vaccine in healthy Chinese infants and young children has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults [Phase 1, Phase 2]
Phase 1/2 trial update on the safety, tolerability, and immunogenicity of the 24-valent pneumococcal conjugate vaccine VAX-24 in adults; stu…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) [Phase 3]
Phase III clinical trial of a candidate PCV13 vaccine in healthy individuals aged 6 weeks and above has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels [Phase 4]
Phase 4 trial comparing sequential versus simultaneous pneumococcal vaccination in elderly, focusing on immunological memory and antibody re…
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-028) [Phase 1]
Phase 1 trial evaluating safety, tolerability, and immunogenicity of the V114 pneumococcal vaccine in healthy Japanese infants; the study is…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of the 23-valent pneumococcal polysaccharide vaccine.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
Phase 4 trial update assessing lot-to-lot consistency of the 23-valent pneumococcal polysaccharide vaccine.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) [Phase 3]
Phase 3 trial assessing safety, tolerability, and immunogenicity of the pneumococcal vaccine V114 in healthy infants has completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years [Phase 4]
Phase 4 trial update evaluating concomitant administration of the Novavax COVID-19 vaccine with a 20-valent pneumococcal conjugate vaccine i…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) [Phase 3]
Phase 3 trial update on a 3-dose V114 regimen in healthy infants assessing safety, tolerability, and immunogenicity; results posted after co…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V114 in healthy Japanese infants has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V114 in allogeneic hematopoietic stem cell transplant recipients has co…
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 trial update of the 23-valent pneumococcal polysaccharide vaccine sponsored by Sinovac Biotech has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK) [Phase 3]
Phase 3 trial assessing safety and tolerability of V114 with Prevnar 13 in healthy infants; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) [Phase 3]
Phase 3 trial update assessing safety, tolerability, and immunogenicity of V114 in healthy infants; results completed with posted findings i…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) [Phase 3]
Phase 3 trial assessing safety and immunogenicity of the PCV20-like vaccine V114 in children with HIV; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants [Phase 2]
Phase 2 study evaluating safety and immunogenicity of a multivalent pneumococcal vaccine with Prevnar 13 in healthy infants; study terminate…